Energy Infrastructure Content Hub VettaFi Voices On: The Outlook for 2024 By Heather BellDecember 8, 2023
Thematic Investing Content Hub As Biotech Adjusts to “New Normal,” Get Exposure With This ETF By Ben HernandezSeptember 23, 2022
Thematic Investing Content Hub Get Exposure to Global X Thematic ETFs in This One Fund By Ben HernandezDecember 21, 2021
Thematic Investing Content Hub Snag Next-Generation Tech Exposure with This Genomics ETF By Ben HernandezJuly 16, 2021
Thematic Investing Content Hub Momentum Investing Is Back. Don’t Miss the Train By Ben HernandezJanuary 19, 2021
Thematic Investing Content Hub Can Global X’s GNOM Be the Next Big ETF? By Ben HernandezJanuary 11, 2021
Thematic Investing Content Hub Get On Board a Growing Biotech Industry With the GNOM ETF By Ben HernandezDecember 23, 2020
Thematic Investing Content Hub The Genomics Market is Poised for Growth Through 2025 By Ben HernandezAugust 17, 2020
Innovative ETFs Content Hub Biotech ETFs Surge After Invitae Acquires ArcherDX By Max ChenJune 22, 2020
Thematic Investing Content Hub A Genomics ETF at the Center of the Coronavirus Fight By Tom LydonJune 18, 2020
Thematic Investing Content Hub Declining Costs Boost Allure of GNOM Genomics ETF By Tom LydonMarch 13, 2020
Thematic Investing Content Hub Why This Thematic Healthcare Could be a January Winner By Tom LydonJanuary 9, 2020
Thematic Investing Content Hub A Young Biotech ETF With Plenty of Potential By Todd ShriberSeptember 6, 2019
Thematic Investing Content Hub A New ETF For Hot Corners of The Biotech Market By Todd ShriberJune 24, 2019
Thematic Investing Content Hub Four Companies Could Power The New Genomics ETF By Todd ShriberApril 15, 2019
Thematic Investing Content Hub Global X Debuts Pure Play Genomics ETF ‘GNOM’ By Brenton GarenApril 9, 2019
